ANDA 85813, held by Rising. Prednisone.
As of Nov 14, 2026, ANDA 85813 (Prednisone), held by Rising, was first approved by FDA on May 31, 1978, with 20 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 31, 1978 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Prednisone20MG ยท tablet;oral | Prednisone | Discontinued |
| Apr 10, 1995 | Supplement 30Manufacturing | Approved | None posted |
| Feb 5, 1991 | Supplement 29Manufacturing | Approved | None posted |
| Aug 3, 1989 | Supplement 28Labeling | Approved | None posted |
| Aug 12, 1987 | Supplement 27Manufacturing | Approved | None posted |
| Feb 11, 1987 | Supplement 26Manufacturing | Approved | None posted |
| Aug 1, 1986 | Supplement 24Manufacturing | Approved | None posted |
| Aug 1, 1986 | Supplement 23Manufacturing | Approved | None posted |
| Aug 1, 1986 | Supplement 22Manufacturing | Approved | None posted |
| Aug 1, 1986 | Supplement 21Manufacturing | Approved | None posted |
| Jan 16, 1986 | Supplement 20Manufacturing | Approved | None posted |
| Jan 16, 1986 | Supplement 19Manufacturing | Approved | None posted |
| Jan 16, 1986 | Supplement 18Manufacturing | Approved | None posted |
| Feb 27, 1985 | Supplement 13Manufacturing | Approved | None posted |
| Sep 21, 1984 | Supplement 12Manufacturing | Approved | None posted |
| Sep 21, 1984 | Supplement 11Manufacturing | Approved | None posted |
| Nov 16, 1982 | Supplement 10Manufacturing | Approved | None posted |
| Jun 18, 1982 | Supplement 9Manufacturing | Approved | None posted |
| Jun 18, 1982 | Supplement 8Manufacturing | Approved | None posted |
| Jun 18, 1982 | Supplement 3Manufacturing | Approved | None posted |
| Jun 18, 1982 | Supplement 2Manufacturing | Approved | None posted |
| May 31, 1978 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters